Welcome to the House Committee on Energy and Commerce

E&C is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care.


The Latest

From the Committee

Feb 12, 2025
Press Release
Chairman Bilirakis Delivers Opening Statement at Subcommittee on Commerce, Manufacturing, and Trade Hearing on American Leadership in Manufacturing

WASHINGTON, D.C. – Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, delivered the following opening statement at today’s hearing titled AI in Manufacturing: Securing American Leadership in Manufacturing and the Next Generation of Technologies.


Subcommittee Chairman Griffith's opening statement as prepared for delivery:

“Good morning everyone and welcome to the first Commerce, Manufacturing, and Trade Subcommittee hearing of the 119th Congress. I’d like to express my sincere congratulations to my good friend, the Chair, Mr. Guthrie, on his appointment to the powerful Energy and Commerce Committee – the oldest standing legislative committee in the House, and the best Committee in Congress.

“I also want to thank the Chair for putting his faith in me to lead this important subcommittee, which has broad jurisdiction over a great many important matters. This will be a busy Congress and I’m excited to lay the groundwork to accomplish a robust legislative agenda.

“I would be remiss if I didn’t identify and welcome to this wonderful panel the new members of the Energy and Commerce Committee:

“Mr. Bentz from Oregon; Ms. Houchin from Indiana; Mr. Fry from South Carolina; Ms. Lee from Florida – and I’ll add a Go Gators to you my friend; Mr. Kean from New Jersey; Mr. Evans from Colorado; and Mr. Goldman from Texas.

“I also want to thank my friend Russ Fulcher from the great State of Idaho for serving as the Vice Chair of this Subcommittee.

“And finally, it is good to be sitting next to my friend, Ms. Schakowsky from Illinois. I’m greatly looking forward to working with you again, and all of the Members of this Subcommittee.”

Artificial Intelligence in Manufacturing

“Now onto the business at hand. I’m excited to kick this Congress off with an educational hearing examining the state of American manufacturing, and how it can be revolutionized with the use of artificial intelligence.

“We know generative AI is currently dominating the headlines for its specific use case of AI, such as how DeepSeek is capturing warranted attention with their collection of American’s personal data and subsequently sharing it with the Chinese Communist Party.

“But I think we must remember that generative AI is only a specific use case of this technology, and AI’s applications are much broader than what has claimed the spotlight recently. We have seen how AI applied to vehicles is paving the way for the next generation of vehicles that will drive themselves. These autonomous vehicles promise to greatly improve auto safety and provide vast mobility benefits to every American – including those with disabilities.

“We have also seen how the technology holds the power to completely revolutionize American manufacturing and bolster our supply chains. 

By integrating AI and machine learning into supply chain systems, we can better predict constraints and find potential weak points which can be used to prevent shocks that disrupt entire industries.

“Our committee has led on supply chain mapping and monitoring legislation before, and empowering companies to deploy emerging technologies like AI to better understand our supply chains could help us protect against the next pandemic or the next major labor shortage. We need to send that legislation to the President’s desk to begin the important work of making America more resilient.

“Industries can also utilize the power of AI in our manufacturing ecosystems to find where redundancies exist and reduce waste in the developmental pipeline. To bring this country back to the forefront of what made it great, we need to reduce unnecessary waste and optimize our building capabilities. We know the American people are the most innovative in the world. Our job here in Congress will be to provide a pathway for these innovators to succeed.

“America’s global leadership in the 21st century will be contingent on our ability to promote emerging technologies and establishing a pathway to unleash them throughout American manufacturing. We have a great panel of witnesses today to share examples of how AI is actively being used in manufacturing and supply chains.

“I want to thank them for being here today amidst the bad weather to give us much needed testimony on such an important topic. I yield back.”

###


More News & Announcements


Feb 12, 2025
Press Release

Chairman Guthrie and Vice Chairman Joyce Announce Creation of Privacy Working Group

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce, M.D. (PA-13), Vice Chairman of the House Committee on Energy and Commerce, announced the establishment of a comprehensive data privacy working group and issued the following statement: “We strongly believe that a national data privacy standard is necessary to protect Americans’ rights online and maintain our country’s global leadership in digital technologies, including artificial intelligence. That’s why we are creating this working group, to bring members and stakeholders together to explore a framework for legislation that can get across the finish line,”  said Chairman Guthrie and Vice Chairman Joyce.   “The need for comprehensive data privacy is greater than ever, and we are hopeful that we can start building a strong coalition to address this important issue.” The working group welcomes input from a broad range of stakeholders. Stakeholders interested in engaging with the working group can reach out to  PrivacyWorkingGroup@mail.house.gov  for more information. Background: The working group will be led by Dr. Joyce, Vice Chairman of the Committee on Energy and Commerce. The working group will also include: Congressman Morgan Griffith (VA-09) Congressman Troy Balderson (OH-12) Congressman Jay Obernolte (CA-23) Congressman Russell Fry (SC-07) Congressman Nick Langworthy (NY-23) Congressman Tom Kean (NJ-07) Congressman Craig Goldman (TX-12) Congresswoman Julie Fedorchak (ND-AL)   ###



Feb 7, 2025
Press Release

Subcommittee on Health Holds Hearing on New and Emerging Drug Threats

WASHINGTON, D.C. —  Congressman Earl L. “Buddy” Carter (GA-01), Chairman of the Subcommittee on Health, led a hearing yesterday titled  Combatting Existing and Emerging Illicit Drug Threats . “One death due to illicit drugs is too many, and this hearing gave members the chance to hear from patient advocates and experts, including law enforcement and medical professionals. Solving the drug crisis will include everything from empowering law enforcement to crack down on drug traffickers to providing support to those struggling with substance use disorder,”  said Chairman Carter.  “This Subcommittee has led on proposing solutions to these problems in the last Congress, and this hearing shows signs that we will continue to do so moving forward.” Watch the full hearing  here . Below are key excerpts from today’s hearing: Rep. John Joyce (PA-13), Vice Chairman of the Committee on Energy and Commerce: “Since the inauguration of President Trump, we have seen President Trump take immediate action to combat the growing threat of illicit fentanyl flowing through our borders. He designated the cartels in Mexico as a foreign terrorist organization and reached an agreement with the Mexican president to deploy her country's National Guard to help stop the transport of this deadly drug into our country. Unfortunately, these positive steps come only a few years after the inaction of the Biden Administration. And because of that delay, fentanyl poisoning has risen dramatically with seven out of 10 illicit fentanyl pills tested by the DEA in 2023 containing a potentially lethal dose of fentanyl. That's seven out of 10, and go back just two years before that, it was only four out of 10. Why would I say only four out of 10 deadly pills? Ray Cullen, thank you for being here. Thank you for sharing the story of your son, Zach. Can you talk about how fentanyl poisoning is distinct from an accidental overdose?”  Ray Cullen:   “Thank you for the question. So, in my opinion, an accidental overdose is when someone takes something—whether prescribed or not—that’s more of what they were supposed to then the body could handle. Poisoning to me means that someone took something that had something in it. that they were not expecting. So, in our case Zach purchased cocaine—bad decision—but the coroner told me that there was more fentanyl and cocaine in his system. He did not die because he took too much cocaine.” Rep. Neal Dunn (FL-02), Vice Chairman of the Subcommittee on Health: “Doctor Westlake, as a medical doctor, I'm interested to hear from you about how this issue presents in the emergency room. Can you speak from your own experience—how the presentations of drug overdoses have evolved over the last few years?”   Dr. Westlake:   “I think when, when we kind of saw the starting, it was with prescription opioid epidemic, and there were overdoses on prescription pills because of the overprescribing issue. That has pretty, pretty much, you know, at least in Wisconsin, and my understanding across the country is pretty much stopped. And now it's moved on to the illicit substances. And then once they became the counterfeit, counterfeit substances, initially it was people that knew they were using and were taking risks, and now moved into people that don't even know that they're that they're using. The majority of overdoses that I see are people that are not aware that they're taking fentanyl. The last 10 overdoses that I've seen in the last couple of months, all thought they were taking heroin, and when we tested it, there was no opioid, it was all pure fentanyl that was they were overdosing from.” ###



Feb 6, 2025
Press Release

Law Enforcement and Advocates Urge Passage of HALT Fentanyl Act

WASHINGTON, D.C. —  Law enforcement and advocacy groups are urging Congress to pass H.R. 27, the HALT Fentanyl Act, led by Committee on Energy and Congress Members Reps. Morgan Griffith (VA-09) and Bob Latta (OH-05). Here’s what they have to say: “We commend your early prioritization of this issue and your leadership in pushing this legislation forward. The opioid epidemic continues to claim the lives of hundreds of Americans every day. As this crisis escalates, every delay in addressing it only increases the toll on our communities. For the sake of public safety, it is imperative that the House pass the HALT Fentanyl Act as it stands, without changes, and move it forward to law.” CLICK HERE  to read the letter from the Association of State Criminal Investigative Agencies (ASCIA), Federal Law Enforcement Officers Association (FLEOA), Major Cities Chiefs Association (MCCA), Major County Sheriffs of America (MCSA), National Alliance of State Drug Enforcement Agencies (NASDEA), National Association of Police Organizations (NAPO), National District Attorneys Association (NDAA), National HIDTA Directors Association (NHDA), National Narcotic Officers’ Associations’ Coalition (NNOAC), National Sheriffs’ Association (NSA), Sergeants Benevolent Association NYPD (SBA). “We, the members of the Drug Enforcement Association of Federal Narcotics Agents, are writing to express our strong support for the Halt All Lethal Trafficking (HALT) Fentanyl Act. This bipartisan legislation is crucial in combating the devastating fentanyl crisis that has become the leading cause of death among young adults aged 18-45.” CLICK HERE  to read the letter from Drug Enforcement Association of Federal Narcotics Agents President Marshall Fisher. “The HALT Fentanyl Act is not just about strengthening law enforcement—it is about saving lives and protecting communities. By permanently scheduling fentanyl analogues, we are sending a strong message that the United States will not tolerate the continued destruction caused by this drug.” CLICK HERE  to read the letter from Association of Mature American Citizens Action Chairwoman Rebecca Weber. “On behalf of the National Association of Police Organizations (NAPO), representing over 241,000 sworn law enforcement officers across the United States, I am writing to you to express our strong support for the Halt All Lethal Trafficking of (HALT) Fentanyl Act.  [...] “NAPO has long fought for resources to support law enforcement’s efforts to combat fentanyl, its analogues, and similar opioids. We thank you for your efforts to help the fight against the spread of this deadly poison in our communities and look forward to working with you to pass this important legislation.” CLICK HERE  to read the letter from NAPO Executive Director William J. Johnson. CLICK HERE  to read more about the HALT Fentanyl Act.   ###


Trending Subcommittees

Commerce, Manufacturing, and Trade


4 Updates

Interstate and foreign commerce, including all trade matters within the jurisdiction of the full committee; consumer protection, including privacy matters generally; data security; motor vehicle safety; regulation of commercial practices (the Federal Trade Commission), including sports-related matters; consumer product safety (the Consumer Product Safety Commission); product liability; and regulation of travel, tourism, and time. The Subcommittee’s jurisdiction can be directly traced to Congress’ constitutional authority “to regulate Commerce with foreign nations, and among the several States, and with the Indian Tribes.”


Communications & Technology


6 Updates

Electronic communications, both Interstate and foreign, including voice, video, audio and data, whether transmitted by wire or wirelessly, and whether transmitted by telecommunications, commercial or private mobile service, broadcast, cable, satellite, microwave, or other mode; technology generally; emergency and public safety communications; cybersecurity, privacy, and data security; the Federal Communications Commission, the National Telecommunications and Information Administration, the Office of Emergency Communications in the Department of Homeland Security; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.


Energy


4 Updates

National Energy Policy, energy infrastructure and security, energy related Agencies and Commissions, all laws, programs, and government activities affecting energy matters. National Energy Policy focuses on fossil energy; renewable energy; nuclear energy; energy conservation, utility issues, including but not limited to interstate energy compacts; energy generation, marketing, reliability, transmission, siting, exploration, production, efficiency, cybersecurity, and ratemaking for all generated power. Energy infrastructure and security focuses on pipelines, the strategic petroleum reserve, nuclear facilities, and cybersecurity for our nation’s grid. Our jurisdiction also includes all aspects of the above-referenced jurisdiction related to the Department of Homeland Security. Agencies and Commissions in our jurisdiction include: The US Department of Energy, the Nuclear Regulatory Commission; and the Federal Energy Regulatory Commission.


Recent Letters


Jan 6, 2025
Press Release

Chairman Guthrie and Chairman Latta Question Energy Department’s Involvement in Biden-Harris Offshore Drilling Ban

WASHINGTON, D.C.  – Yesterday, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, along with Congressman Bob Latta (OH-05), Chairman of the Subcommittee on Energy, penned a letter to Secretary Jennifer Granholm questioning the Department of Energy’s involvement in the Biden-Harris Administration’s decision to prevent new offshore oil and gas production, leading to higher prices for consumers and harming U.S. energy security. KEY LETTER EXCERPT: “Closing off swaths of U.S. offshore areas to energy production, as the Biden-Harris Administration reportedly intends to do, will lead to higher energy prices for American families, the loss of American jobs, and greatly diminish our country’s energy security. As the Secretary of Energy, you have an obligation to weigh in on this matter and insist on a full review of the energy security and economic impacts before any decisions are finalized. “The United States stands at an energy crossroads, facing mounting global security threats and soaring demand for power. Instead of leading the world in energy production, we’ve allowed misguided “green” policies to hamstring our potential. It’s time to unleash American energy dominance again—the federal government must become an ally, not an obstacle, to our nation’s energy security. We look forward to your prompt response to this request, no later than January 10, 2025.” Read the story  here . BACKGROUND: This morning, the Biden Administration announced that more than 625 million square miles of coastline would be off-limits for energy production. Republican Members of the House Committee on Energy and Commerce have continuously called on the Biden-Harris Administration to end its attack on American energy production before leaving office on January 20th. The letter requests an explanation of the DOE’s involvement in the decision and whether the White House or the Department of Interior consulted with the DOE about the plans to close off access to offshore resources. Any decision to shut down access to significant American energy resources impacts U.S. energy policy and should be reviewed by the DOE. The Biden Administration’s energy policies have continued to create major harm to America’s energy production and workforce. A unilateral ban on energy production in large swaths of the U.S. coastline will have lasting impacts on American energy production and security.



Dec 19, 2024
Press Release

E&C Republicans Request HHS Watchdog Investigate Promotion of Gender Transition Procedures for Children

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Inspector General Christi Grimm, House Energy and Commerce Committee Republicans requested an investigation into the strength, quality, and types of evidence-based scientific and pediatric medical literature relied on by the department to promote gender transition procedures for children.  KEY LETTER EXCERPT:  “As the agency responsible for safeguarding the health and well-being of Americans, all of HHS’s medical treatment recommendations, especially medical treatment recommendations for children, should be based on rigorous and well-established research, such as randomized controlled trials, that have definitively illustrated the long-term benefits of gender affirming care treatments.”  BACKGROUND:  Under the Biden administration, HHS has advocated for sex reassignment procedures on minors, including the use of serum puberty blockers, which have historically been used to treat children with precocious puberty (i.e., early onset puberty affecting about one percent of U.S. children) and sex offenders.   Puberty blockers, however, are known to stunt normal childhood development in children unaffected by precocious puberty.  HHS officials contend that sex reassignment procedures on minors are an unanimously accepted medical practice.  HHS Secretary Becerra testified before Congress that “every major medical association,” “medical journals,” and “scientific and medical evidence” has demonstrated the benefits of transitioning children’s biological sex.  When asked, via a Freedom of Information Act request, for the underlying scientific or medical basis for its position, HHS was only able to produce a two-page brochure that was already publicly available.  In contrast to HHS, a growing body of literature from medical experts and authorities around the world, including those in Europe, caution against performing such procedures on minors.   Courts and government health agencies responsible for determining child welfare have sought to limit child sex reassignment procedures.   Other countries have banned these interventions and surgeries on minors altogether.  An article published in the British Journal of Medicine found “there is great uncertainty about the effects of puberty blockers, cross-sex hormones, and surgeries in young people.”   A court in the United Kingdom noted the obvious about administering puberty blocking chemicals onto children: “[i]t is highly unlikely that a child aged 13 or under would be competent to give consent to the administration of puberty blockers. It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers.”  In April 2024, the Cass Review , an independent review of gender identity services for children and young people, commissioned by the National Health Service England, found “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.”   The Cass Review also found that “[t]he rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” as well as unknown effects on cognitive and psychosexual development.  In August 2024, the American Society of Plastic Surgeons (ASPS) became the first major U.S. medical association to express caution on the use of gender surgery for gender dysphoria in adolescents. In its formal statement, the association stated: “ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations.”   The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA), Rep. Dan Crenshaw (R-TX), Rep. Gus Bilirakis (R-FL), Rep. Buddy Carter (R-GA), Rep. Gary Palmer (R-AL), Rep. Neal Dunn (R-FL), Rep. Randy Weber (R-TX), Rep. Troy Balderson (R-OH), Rep. August Pfluger (R-TX), Rep. Diana Harshbarger (R-TN), and Rep. Kat Cammack (R-FL).  CLICK HERE to read the letter.



Nov 22, 2024
Press Release

E&C, E&W Republicans Press Gladstone Institutes for Information Regarding Internal Antisemitism

House Republicans scrutinize government grant funding recipients that fail to protect individuals from antisemitism Washington, D.C. — In a new letter to J. David Gladstone Institutes President Dr. Deepak Srivastava, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) have requested information about ongoing and pervasive acts of antisemitic harassment and intimidation at Gladstone and its leadership’s insufficient response to these acts. The letter is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY LETTER EXCERPTS: “The Gladstone Institutes, an independent biomedical research organization, claims that it takes an active stance against serious issues like discrimination and harassment and aims to ‘ensure all community members at Gladstone feel included’ and that the Institutes will aim to ‘implement accountability measures and reinforce Gladstone’s commitment to having an environment free of harassment.’ However, these values do not seem to be reflected in the actions of leadership in response to recent concerns of antisemitic harassment and discrimination within the Institutes.” [...] “The reports of antisemitic harassment at Gladstone coupled with the inadequate response by leadership is concerning to the Committees. Failing to act decisively to ensure a safe environment for all trainees, faculty, and staff is a grave dereliction of your responsibilities as President of Gladstone.” “Failing to comply with basic safety protections for members of Gladstone or failure to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university. Congress has an obligation to exercise oversight of recipients of federal funds when blatant and ongoing Title VI violations appear to be happening. If Congress determines an institution of higher education/research is blatantly ignoring its legal responsibilities, we may consider rescinding research and development funds previously appropriated.” BACKGROUND ON TAXPAYER FUNDING: Gladstone received more than $41 million in funding from the NIH in Fiscal Year 2023, not including potential taxpayer funding that individual faculty may have received through their affiliation with the University of California, San Francisco (UCSF) or any other affiliated universities.   According to the NIH’s Grant Policy Statement, any institution receiving federal funds must assure work environments are free of discriminatory harassment and are safe and conducive to high-quality work.  Institutions receiving federal taxpayer financial assistance—such as NIH grants—are prohibited from discriminating based on a variety of categories, including national origin.   These laws also protect members of the institution who are or are perceived to be members of a group with shared ancestry, such as students/trainees of Jewish heritage. BACKGROUND ON INSTANCES OF ANTISEMITISM : Two days after the October 7, 2023, Hamas terrorist attack, a graduate student working in a lab within Gladstone sent an antisemitic email to all Gladstone faculty, trainees, and staff falsely stating that the attack on innocent Israeli civilians was “the resistance in Gaza launch[ing] a surprise attack against Israel, taking occupation soldiers hostage, taking over Israeli military vehicles, and gain[ing] control over illegal Israeli settlements.”  The email goes on to claim that all casualties resulting from Palestinian actions are the responsibility of Israel.  Immediately following this mass email, members of the Gladstone faculty began contacting the Gladstone Institutes’ President and other leadership, appalled by the language of the email, concerned for their safety and worried that the email could be seen as an incitement to violence.  Jewish members of the Institutes also expressed their deep, personal pain following the Hamas attack, as some members had family or friends reported killed or missing directly after the attack.  These fears—including fears of being attacked in the lab by the author of this cruel and antagonistic email—were shared directly with President Srivastava.  Despite this, Gladstone leadership did not issue a public statement or position against antisemitism to quell fears of Jewish faculty and trainees.  In May 2024, the Center for Combatting Antisemitism sent President Srivastava a letter requesting administrative action to address the hostile environment and disparate treatment of Jewish members at Gladstone.  This letter noted that Gladstone refused to acknowledge Jewish American Heritage Month, Passover, or Holocaust Remembrance Day, despite sending official celebratory emails and holding events for other religious, ethnic, or national holidays, including Black History Month, International Women’s Day, and Ramadan.  The Center followed up with Gladstone several times, but never received a response.  Jewish faculty and trainees have conveyed to leadership within Gladstone instances of antisemitic harassment and discrimination, which faculty and trainees believe were not taken seriously, making some feel uneasy about speaking out.  For example, per a publicly available Fair Employment and Housing Act complaint to the California Civil Rights Division, a Jewish faculty member openly discussed fellow faculty using racial stereotypes, including comments about a “Jewish nose.”  When these comments were brought to human resources, no investigation occurred.  Instead, the complainant was subsequently targeted with an investigation ultimately deemed to be unwarranted.  Then, following the complainant’s post-October 7th advocacy on behalf of Jewish faculty and trainees, the complainant was threatened repeatedly with career-ending termination, allegedly in an attempt to extort a resignation.  When the threats did not have their desired effect, Gladstone placed the complainant on administrative leave and removed the complainant’s electronic access to email and files but also physical access to the complainant’s lab, removing all ability to conduct work on an NIH-funded grant.  Gladstone ultimately paid an undisclosed sum to settle the matter and avoid litigation.  To elevate concerns regarding widespread, ongoing discrimination, Jewish faculty and trainees requested permission to bring in a speaker related to antisemitism.  Other minority groups had previously been given permission to bring in similar anti-racism speakers.  However, while leadership stated it would look into the idea, ultimately no speaker was brought, and no program was launched regarding antisemitism. BACKGROUND ON AFFILIATIONS WITH OTHER INSTITUTIONS UNDER INVESTIGATION : Gladstone Institutes is affiliated with other institutions under congressional investigation.  For example, Gladstone is an affiliate of the UCSF, which is undergoing congressional investigation for reports of antisemitism within the university, medical school, and medical centers.  Most of Gladstone’s principal investigators are also faculty at UCSF, and the Institutes provide research positions and opportunities for graduate students from UCSF.  Moreover, there is a joint institute—the Gladstone-UCSF Institute of Genomic Immunology—further linking the two institutions.  Gladstone is also affiliated with the University of California, Berkeley and Stanford University, both of which are also under investigation for concerns related to antisemitism. CLICK HERE to read the full letter.